Androgens, antiandrogens and androgen receptor abnormalities

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• The molecular structure of the human androgen receptor (AR) is crucial for understanding androgen and antiandrogen mechanisms.
• AR gene defects are implicated in prostate cancer development and progression.
• Somatic mutations in the AR gene are frequently found in prostate tumors.

Purpose of the Study:

• To investigate the role of specific androgen receptor mutations in prostate cancer.
• To understand how these mutations affect receptor function and response to therapy.
• To explore the implications of AR mutations in advanced and metastatic prostate cancer.

Main Methods:

• Analysis of molecular structure of the human androgen receptor.
• Detection and characterization of somatic mutations in tumor specimens from prostate cancer patients.
• Investigation of ligand responsiveness of mutant androgen receptors.

Main Results:

• Several AR mutations are detected in prostate tumors, primarily in the ligand-binding domain.
• The Thr868Ala mutation is frequent in metastatic prostate cancer, especially bone metastases, and is considered a hot spot.
• Some AR mutations increase ligand responsiveness to various hormones and antiandrogens, potentially allowing receptor activation in castrated patients or during antiandrogen therapy.

Conclusions:

• Specific AR mutations, like Thr868Ala, may confer a growth advantage in advanced prostate cancers.
• Altered ligand responsiveness of mutant ARs could explain why some patients benefit from antiandrogen withdrawal.
• Understanding AR mutations is vital for developing targeted therapies for prostate cancer.